• DATABASE (45)

  • ARTICLES (79)

    • DATABASE (45)
    • ARTICLES (79)
  • Sort by
    • Relevance
    • Date

Spain's most popular second-hand marketplace merged with LetGo in 2017 in the US and has 6 million daily users and topped US$150 million in funding.

Charles Guinot is founder of Indonesian online tax services platform OnlinePajak and a project manager and board member at Farinia Group, a French multinational manufacturing business group. Guinot earned his bachelor’s in Mechanical Engineering from Université de Technologie de Troyes, France and holds master’s degrees in Mechatronics from the Université de Technologie de Compiègne, France and Manufacturing Engineering from the City University of Hong Kong.

Creadev was created in 2002 in France as the private equity arm of the Mulliez family. Creadev expanded to Shanghai in 2012, through a unit called Crehol China. It has since been renamed Creadev China.  

Founded in 2002, Galia Gestion is an investment fund based in Bordeaux and operating principally in southwest France. To date, it has supported some 150 companies and currently has €100m of investments under management. 

IRDI Capital Investissement supports innovative startups and local SMEs in southwest France, with offices in Bordeaux, Toulouse, and Montpellier. Over its 40-year history, the company has invested some €800m in more than 1,400 companies. 

Philippe Gelis is a co-founder and CEO of Kantox, a foreign currency exchange management platform. Born in Narbonne, France, in 1979, he now lives in Barcelona where the company's main offices are located. Prior to setting up Kantox in 2011, Gelis worked as a strategy and management consultant at Deloitte and as a financial consultant at Axis Corporate. His first job was as financial controller at Renault, Switzerland. Gelis holds a master's in Business Strategy and an MBA in Corporate Finance, both from Toulouse Business School, France. 

Cathay Innovation invests in small to medium-sized companies with the potential to rapidly grow internationally. By 2016, Cathay Innovation had conducted 59 investments, with a total investment of €514 million. It has offices in France, China, the US and Germany, with €1.2 billion under management.

Backed by €2m from impact investors, Les Noveaux Affineurs is ramping up production of its plant-based, French vegan cheese gastronomy for export to international markets

Therapixel’s award-winning AI-powered MammoScreen technology helps radiologists read digital mammograms and obtain accurate breast cancer screening results within minutes.

TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.

Ex-McKinsey consultant and Amadeus engineer Jaime Laulhé lived in New York, Paris and Hong Kong before returning to his native Madrid to work at McKinsey, where he spent two years. He holds degrees in IT Engineering from Madrid Polytechnic University and in Telecommunications Engineering from ENSIMAG in France, and an MBA from the University of Chicago and a master's in Mathematics from Institut Fourier, France.In New York and Hong Kong, he spent several years working in High Frequency Trading tech at Société Générale. He is founder and CEO of Geoblink, developing location tech AI solutions for retail, real estate and FMCG sectors.

China Minsheng Investment Group (CMIG) is the largest privately owned investment group in China, with RMB 50 billion in registered capital. It was initiated by the All-China Federation of Industry and Commerce, and its Global Advisory Council includes the former prime ministers of France, Italy and Pakistan, and various other global experts and Nobel Prize winners.

Phitrust Partenaires is a France-based investment fund focused on social businesses in Europe and Asia.In Europe, the company acts as a VC firm dedicated to impact investing. Its investment vehicle contributes €150,000 to €800,000 to support projects that address social needs. Phitrust Partenaires also works in partnership with prominent European social funds.

Nour Akbaraly completed a master’s in engineering at Centrale Lille and also a master’s in applied mathematics at Lille University in 2010. In 2011, Akbaraly joined industrial manufacturing consultancy firm Avencore as a consultant in Paris.The avid photographer and F&B enthusiast also went to various tea-tasting classes at a tea specialist college until 2015. Passionate about gastronomy, he began exploring alt-protein alternatives to address the environmental and ethical challenges of food supply chains.In 2016, he went on an engineering training course for agronomy and agri-food at AgroSup Dijon, the National Institute of Agronomic, Food and Environmental Sciences.A year later, he founded Les Noveaux Affineurs, a startup specializing in plant-based alternatives to cheese. His ambition is to create a new range of French gastronomic vegan cheese products for consumers in France and overseas.Since 2010, Akbaraly is also a volunteer at the Action Contre la Faim, a Paris-based international NGO founded in 1979. The “Action Against Hunger” projects include running awareness campaigns on food security issues in colleges and schools in France and other countries like India and Sudan.

Bristol Myers Squibb or BMS is one of the world’s largest biopharmaceutical companies developing medicines in oncology, hematology, immunology and cardiovascular disease. It invests directly and via VC funds, including Life Sciences Partners (LSP) and BioGeneration Ventures, as LP. BMS is headquartered in New York and has 10 offices and facilities within the US and 13 in overseas locations, namely, Puerto Rico, Canada, France, Belgium, the UK, Ireland, Germany, Japan and China. 

Sorry, we couldn’t find any matches for“France”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.